Marta Villalba Montaner

🎓 ¡Enhorabuena al Dr. Miguel Mansilla Polo por la defensa de su tesis! 💫 Se trata de una investigación, dirigida por los Dres. Rafael Botella y Jaime Sanz, sobre cáncer cutáneo en receptores de TPH que impulsa el avance en dermatología tras el trasplante.

PEDRO IS ON FIRE! The level of insight he’s generating is unreal. What a team!!astctjournal.org/article/S2666-… @TheEBMT @GETH_info @IISLaFe

First results are in the multidisciplinary GVHD team at LA FE @IISLaFe @TheEBMT @GETH_info .astctjournal.org/article/S2666-…

Another one! What an incredible year it’s been! Huge congrats to Juan on the EBMT study collaboration on HSCT in ALL. Now for a well-deserved summer break!@ @IISLaFe @Mohty_EBMT @TheEBMT @GETH_info @HospitalLaFe nature.com/articles/s4140…

El Hospital La Fe supera los 100 trasplantes de médula ósea - Actualidad Valencia #SomosLaFe actualidadvalencia.com/el-hospital-la…

Another one accepted! The team's on an incredible streak — what a year we're having! Engraftment Syndrome after Post-Transplant Cyclophosphamide Allogeneic Hematopoietic Cell Transplantatio… pubmed.ncbi.nlm.nih.gov/40490079/ @TheEBMT @GETH_info @IISLaFe @HospitalLaFe

Another one! Big congrats to Aitana! Our team's scientific production is unstoppable! Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosp… pubmed.ncbi.nlm.nih.gov/40404101/ @GETH_info @TheEBMT @IISLaFe @HospitalLaFe

A new manuscript in collaboration with the EBMT. This time about aplastic anemia. What a productive year it's been for the Unit. Donor impact on allo-SCT outcomes with PTCy for SAA: a study of the SAAWP EBMT pubmed.ncbi.nlm.nih.gov/40425810/ @GETH_info @HospitalLaFe @TheEBMT @IISLaFe

Congratulations to the team on the new manuscript! We continue to push forward—great work Pedro!! Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide pubmed.ncbi.nlm.nih.gov/40068801/ @GETH_info @GVAsanitat @IISLaFe @HospitalLaFe @TheEBMT

Another manuscript! This from our colleague from Chile, who chose to stay with the team not just to learn, but to actively drive impactful research. CRS syndrome: implications for transplant outcomes in haplo and HLA-matched HSCT using PTCy @GETH_info" target="_blank" rel="nofollow noopener">pubmed.ncbi.nlm.nih.gov/40269279/@GETH… @TheEBMT

📊 Memoria TPH 2024 publicada ❤️ 101 pacientes alotrasplantados Un año más, seguimos como el centro nacional con mayor actividad en alo-TPH. Gracias a todos los que lo hacéis posible. Enhorabuena, equipo. @GVAsanitat @HospitalLaFe @GETH_info @TheEBMT @IISLaFe @ONT_esp @fcarreras

T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy ashpublications.org/blood/article-… Severe (Grade 3+) T-ICAHT is strongly associated with increased transfusion burden and inferior survival following CAR T-cell therapy.

🏥La Fe formaliza la creación de un comité multidisciplinar para el abordaje de la enfermedad de #injerto contra receptor ‼️Es una complicación inmunológica, multiorgánica y potencialmente mortal 🔗organismes.san.gva.es/es/web/lafe/-/…

@MartaVM90 Relapse patterns after antiCD19 #CART cell therapy + role of allo #SCT, by @aitana_balag , project in collaboration with Dr Mussetti, from @HematICO_Hosp

@MartaVM90 T-ICAHT, a novel grading system for #CART cell therapy, presented by Jaime Sanz

Impact of donor undergoing #SCT for high risk #AML, by @MartaVM90

@TPHLaFe @HospitalLaFe @GETH_info Equipazo!

This #EBMT25 our group is on fire!! Four oral communications (including Juan Montoro at the Presidential Symposium), two posters. Well done! 👏👏@HospitalLaFe @GETH_info #SCT

Impact of donor in severe aplastic anemia undergoi g allo#SCT with PTCy by Juan Montoro

RT @AML_Hub: CONGRESS | #EBMT25 @TheEBMT | PRESENTATION @MartaVM90, @HospitalLaFe, shares findings from a retrospective study evaluating th…